Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer-Reference-Cited by-同舟云学术

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer

Published:2016-02-16 Issue:1 Volume:18 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Ali H. Raza^ORCID,Dariush Aliakbar,Provenzano Elena,Bardwell Helen,Abraham Jean E.,Iddawela Mahesh,Vallier Anne-Laure,Hiller Louise,Dunn Janet. A.,Bowden Sarah J.,Hickish Tamas,McAdam Karen,Houston Stephen,Irwin Mike J.,Pharoah Paul D. P.,Brenton James D.,Walton Nicholas A.,Earl Helena M.,Caldas Carlos

Funder

Cancer Research UK (GB)

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-016-0682-8.pdf

Reference35 articles.

1. Killelea BK, Yang VQ, Mougalian S, Horowitz NR, Pusztai L, Chagpar AB, et al. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. J Am Coll Surg. 2015;220(6):1063–9.

2. Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72.

3. Berruti A, Amoroso V, Gallo F, Bertaglia V, Simoncini E, Pedersini R, et al. Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. J Clin Oncol. 2014;32(34):3883–91.

4. Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012;48(18):3342–54.

5. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011;305(18):1873–81.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral epithelial dysplasia detection and grading in oral leukoplakia using deep learning;BMC Oral Health;2024-04-09

2. Spatial Biology of Breast Cancer;Cold Spring Harbor Perspectives in Medicine;2023-12-18

3. Medical imaging and multimodal artificial intelligence models for streamlining and enhancing cancer care: opportunities and challenges;Expert Review of Anticancer Therapy;2023-12-02

4. Artificial intelligence in diagnostic pathology;Diagnostic Pathology;2023-10-03

5. Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer;npj Breast Cancer;2023-09-27